283 related articles for article (PubMed ID: 26647716)
1. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.
Codagnone M; Cianci E; Lamolinara A; Mari VC; Nespoli A; Isopi E; Mattoscio D; Arita M; Bragonzi A; Iezzi M; Romano M; Recchiuti A
Mucosal Immunol; 2018 Jan; 11(1):35-49. PubMed ID: 28422188
[TBL] [Abstract][Full Text] [Related]
4. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
5. Infection regulates pro-resolving mediators that lower antibiotic requirements.
Chiang N; Fredman G; Bäckhed F; Oh SF; Vickery T; Schmidt BA; Serhan CN
Nature; 2012 Apr; 484(7395):524-8. PubMed ID: 22538616
[TBL] [Abstract][Full Text] [Related]
6. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H
J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
Sun YP; Oh SF; Uddin J; Yang R; Gotlinger K; Campbell E; Colgan SP; Petasis NA; Serhan CN
J Biol Chem; 2007 Mar; 282(13):9323-9334. PubMed ID: 17244615
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
Isopi E; Mattoscio D; Codagnone M; Mari VC; Lamolinara A; Patruno S; D'Aurora M; Cianci E; Nespoli A; Franchi S; Gatta V; Dubourdeau M; Moretti P; Di Sabatino M; Iezzi M; Romano M; Recchiuti A
Front Immunol; 2020; 11():581. PubMed ID: 32528461
[TBL] [Abstract][Full Text] [Related]
9. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
[TBL] [Abstract][Full Text] [Related]
10. Resolution of sickle cell disease-associated inflammation and tissue damage with 17
Matte A; Recchiuti A; Federti E; Koehl B; Mintz T; El Nemer W; Tharaux PL; Brousse V; Andolfo I; Lamolinara A; Weinberg O; Siciliano A; Norris PC; Riley IR; Iolascon A; Serhan CN; Brugnara C; De Franceschi L
Blood; 2019 Jan; 133(3):252-265. PubMed ID: 30404812
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
12. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
[TBL] [Abstract][Full Text] [Related]
14. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways.
Dalli J; Ramon S; Norris PC; Colas RA; Serhan CN
FASEB J; 2015 May; 29(5):2120-36. PubMed ID: 25713027
[TBL] [Abstract][Full Text] [Related]
15. Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling.
Leroy V; Cai J; Tu Z; McQuiston A; Sharma S; Emtiazjoo A; Atkinson C; Upchurch GR; Sharma AK
J Heart Lung Transplant; 2023 May; 42(5):562-574. PubMed ID: 36628837
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs.
Li W; Shepherd HM; Terada Y; Shay AE; Bery AI; Gelman AE; Lavine KJ; Serhan CN; Kreisel D
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302938120. PubMed ID: 37487095
[TBL] [Abstract][Full Text] [Related]
17. High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
Patel VS; Sitapara RA; Gore A; Phan B; Sharma L; Sampat V; Li JH; Yang H; Chavan SS; Wang H; Tracey KJ; Mantell LL
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):280-7. PubMed ID: 23087050
[TBL] [Abstract][Full Text] [Related]
18. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
[TBL] [Abstract][Full Text] [Related]
19. PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation.
Hubbard LL; Wilke CA; White ES; Moore BB
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1050-8. PubMed ID: 21527775
[TBL] [Abstract][Full Text] [Related]
20. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
